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Leishmaniasis is a vector-borne disease transmitted by bites of phlebotomine sand ﬂies.
During Leishmania transmission, sand ﬂy saliva is co-inoculated with parasites into the skin
of the mammalian host. Sand ﬂy saliva consists of roughly thirty different salivary proteins,
many with known roles linked to blood feeding facilitation. Apart from the anti-hemostatic
capacity of saliva, several sand ﬂy salivary proteins have been shown to be immunogenic.
Immunization with a single salivary protein or exposure to uninfected bites was shown to
result in a protective immune response against leishmaniasis. Antibodies to saliva were
not required for this protection. A strong body of evidence points to the role for saliva-
speciﬁc T cells producing IFN-γ in the form of a delayed-type hypersensitivity reaction at
the bite site as the main protective response. Herein, we review the immunity to sand ﬂy
salivary proteins in the context of its vector–parasite–host combinations and their vaccine
potential, as well as some recent advances to shed light on the mechanism of how an
immune response to sand ﬂy saliva protects against leishmaniasis.
Keywords: sand fly, salivary proteins, Leishmania, Lutzomyia longipalpis, Phlebotomus papatasi, Phlebotomus
duboscqi
INTRODUCTION
Leishmaniasis is a vector-borne neglected disease caused by pro-
tozoan parasites of the genus Leishmania. The disease is endemic
in 98 countries with an estimated 350 million people at risk of
acquiring leishmaniasis, an incidence of two million new cases
each year,and an estimatedburdenof 2,357,000disability-adjusted
life years (WHO, 2010). The clinical manifestation includes cuta-
neous, mucocutaneous, diffuse cutaneous, and visceral leishma-
niasis (VL) forms. VL is fatal if untreated and the morbidity and
stigma caused by cutaneous leishmaniasis (CL) is considerable
(Desjeux, 2004).
Leishmaniasis is transmitted to the host by an infected sand ﬂy
bite. During feeding, the female phlebotomine will probe the skin
lacerating superﬁcial capillaries and leading to the formation of
a blood pool. Sand ﬂies will actively secrete salivary proteins into
the dermis in order to facilitate blood feeding, avoiding hemosta-
sis, and reducing inﬂammation (Lerner et al., 1991; Charlab et al.,
1999; Kamhawi, 2000). The signiﬁcance of sand ﬂy saliva in leish-
maniasis research was captured some 25 years ago (Ribeiro, 1987)
with the demonstration that sand ﬂies are much more than just
chauffeurs for Leishmania parasites. The fact that sand ﬂy sali-
vary proteins are obligatorily inoculated with parasites within the
skin of the vertebrate host is an important initial step that is still
overlooked, particularly because protective vaccines against Leish-
mania infective-challenge delivered by needle failed to control a
vector-borne challenge (Peters et al., 2009) while multiple expo-
sures to sandﬂy saliva induce an immune response that can control
leishmaniasis in animal models (Belkaid et al., 1998). Transcrip-
tomics of sand ﬂy salivary glands led to the identiﬁcation of the
secreted salivary proteins and the characterization of the function
and immunogenic potential for some of these proteins (Oliveira
et al., 2009). Salivary proteins with protective immune responses
against leishmaniasis in animal models were identiﬁed but chal-
lenges remain to validate their protective role in humans. This
review will focus on the alterations of the host immune system by
anti-saliva immunity and how in turn it can control leishmaniasis.
SAND FLY SALIVA ENHANCES LEISHMANIA INFECTION
The classical work by Titus and Ribeiro (1988) demonstrated that
the infectionwith Leishmaniamajor is signiﬁcantly exacerbated by
the presence of Lutzomyia longipalpis saliva, a New World sand ﬂy.
Its saliva contains a 6.5-kD peptide named maxadilan, which is a
well-characterized salivary molecule working as a potent vasodila-
tor (Lerner et al., 1991). Maxadilan can also act by inhibiting or
modulating the inﬂammatory and immune response of mice, sug-
gesting it contributes to the disease-exacerbating qualities of L.
longipalpis saliva (Morris et al., 2001). The addition of maxadi-
lan to mouse macrophage upregulates cytokines associated with
Th2 response (IL-6, IL-10, and TGF-β) but downregulates Th1
cytokines (IL-12p70 andTNF) andnitric oxide (NO) (Brodie et al.,
2007). Dendritic cells (DC) exposed to maxadilan showed reduced
expression of co-stimulatory molecules (CD80 and CD86) and
chemokine (CCR7) expression and induced secretion of type 2
cytokines suggesting that maxadilan can act not only on DC phe-
notype,but also on the function of those cells,which can be impor-
tant to control the infection against Leishmania (Wheat et al.,
2008). Maxadilan also inhibits T cell activation, decreasing the
production of TNF, H2O2, and nitric oxide (NO), molecules that
are important in the destruction of L. major (Qureshi et al., 1996;
Soares et al., 1998; Gillespie et al., 2000). It was recently shown
that L. longipalpis saliva induced lipid body formation in murine
macrophages in vitro and in vivo and these lipid bodies were linked
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with the production of prostaglandin E2 (Araujo-Santos et al.,
2010) a molecule that could act on parasite dissemination. Consis-
tently with previous results using murine macrophages or mono-
cytes, the incubation of P. papatasi, P. sergenti, or L. longipalpis
saliva reduced proliferation of mitogen-activated murine spleno-
cytes and markedly inhibited the production of the Th1 cytokine
IFN-γ (Rohousova et al., 2005b). Human DC, neutrophils, and
monocytes were also affected by L. longipalpis saliva incubation.
L. longipalpis saliva induced apoptosis of neutrophils leading to
an increase in parasite burden (Prates et al., 2011), altered the
expression of co-stimulatory molecules in DC, macrophages, and
monocytes (Costa et al., 2004) and down-regulated the produc-
tion of TNF and IL-12p40 in LPS-stimulated monocytes (Costa
et al., 2004). Trying to mimic the natural route of infection in a
murine model of CL, Belkaid et al. (1998) demonstrated that the
injection of a low number of L. major plus saliva of its natural
vector Phlebotomus papatasi also enhanced the infection in the
ear dermis of naïve mice. AMP and adenosine present in P. pap-
atasi saliva seems to be involved in the exacerbation observed in
this model (Ribeiro et al., 1999; Katz et al., 2000). Adenosine is
an immunomodulatory component, inducing IL-10 production
and suppressing TNF-α and IL-12 in the mouse model (Hasko
et al., 1996, 2000). It also has the capacity to down-regulate the
expression of the inducible nitric oxide (NO) synthase gene in
activated macrophage and inhibits the production of NO as well
(Katz et al., 2000). AMP and adenosine from P. papatasi saliva
were used to treat an experimental murine model of arthritis.
Thesemolecules acted onDC function reducing theTh17 immune
response and suppressing the autoimmune response (Carregaro
et al., 2011). Additionally, it was demonstrated that P. papatasi
saliva induces IL-4 at the site of inoculation in mice and that effect
was abrogated when IL-4 knockout mice were used (Belkaid et al.,
1998). This body of work highlights the Th2 potential of sand ﬂy
saliva helping to explain the consistent exacerbatory role of saliva
in leishmaniasis. Nevertheless, treatment of human macrophages
with L. intermedia saliva resulted in a decrease of IL-10 produc-
tion and increase in co-stimulatory molecule expression (Menezes
et al., 2008). Interestingly, if L. braziliensis is present during the
treatment of macrophages with saliva, it leads to an increase in
production of TNF, IL-6, and IL-8 pro-inﬂammatory cytokines
without a modiﬁcation in the parasite loads (Menezes et al., 2008).
Differences in the composition of the saliva of these vectors may
explain the conﬂicting roles of saliva after in vitro incubation.
IMMUNITY TO SAND FLY BITES
Sand ﬂy saliva has immunomodulatory properties, but it is impor-
tant to point out that many of these components are proteins and
therefore have the potential to be immunogenic. In fact it has been
shown that multiple exposures to sand ﬂy bites induce speciﬁc
immunity that can be detected by the presence of antibodies and
cellular immune responses. It is remarkable that all tested vec-
tor sand ﬂy species from New and Old World were able to induce
immune responses in several hosts. In laboratory settings, immune
responses to the sand ﬂy salivary proteins have been consistently
shown in mice, hamsters, dogs, and humans following repeated
exposure to bites or by injection of salivary glands dissected from
female P. argentipes, P. ariasi, P. papatasi, P. sergenti, L. longipalpis,
and L. intermedia (Ghosh andMukhopadhyay, 1998; Belkaid et al.,
2000; Kamhawi et al., 2000; Morris et al., 2001; Valenzuela et al.,
2001; Silva et al., 2005; Thiakaki et al., 2005; Oliveira et al., 2006,
2008; de Moura et al., 2007; Jochim et al., 2008; Collin et al., 2009;
Drahota et al., 2009; Ahmed et al., 2010; Ben Hadj Ahmed et al.,
2010; Clements et al., 2010; Rohousova et al., 2011; Vlkova et al.,
2011). Additionally, hosts living in sand ﬂy prevalent areas also
present with an immune response to sand ﬂy salivary proteins.
The presence of antibodies in humans, dogs and foxes in endemic
areas of leishmaniasis has been well documented raising an oppor-
tunity to use anti-saliva antibodies as markers of vector exposure
(Barral et al., 2000; Gomes et al., 2002, 2007; Rohousova et al.,
2005a; Silva et al., 2005; Bahia et al., 2007; de Moura et al., 2007;
Vinhas et al., 2007; Hostomska et al., 2008; Aquino et al., 2010;
Souza et al., 2010; Teixeira et al., 2010; Vlkova et al., 2011). Apart
from being epidemiological tools, anti-saliva antibodies have been
linked to increased risk of CL caused by L. tropica (Rohousova
et al., 2005a), L. braziliensis (de Moura et al., 2007), or L. major
(Marzouki et al., 2011) in Turkey, Brazil, and Tunisia, respectively.
On the other hand, the presence of antibodies to salivary proteins
from sand ﬂy vectors of VL correlated with protection in humans
(Gomes et al., 2002; Aquino et al., 2010) and more recently in
dogs (Vlkova et al., 2011). Taken together, these data suggest that
the association of anti-sand ﬂy saliva antibodies and risk of CL or
VL, albeit contradictory, are probably not random. We can specu-
late that neutralization of sand ﬂy salivary proteins by anti-saliva
antibodies during the initial events after sand ﬂy transmission
of parasites may be linked with protection from VL. Blockage of
salivary bioactive molecules that act on hemostasis could impair
migration of parasitized cells to the peripheral circulation dimin-
ishing Leishmania infection in the liver, bone marrow, and spleen.
Nevertheless, a role of immune complexes generated by anti-saliva
antibodies could likewise lead to local vasculitis, inﬂammation,
and worsen local inﬂammation leading to a greater availability
of harboring cells in the skin, particularly neutrophils, that could
exacerbate the outcome of CL. It is unlikely that the causal expla-
nation is due to an increased preference of the sand ﬂy vectors
for some individuals in these endemic areas, leading to a higher
selective exposure to sand ﬂy bites. The role of antibodies to sand
ﬂy saliva during parasite transmission, establishment, and disease
manifestation needs further scrutiny and maybe related to factors
pertinent to the VL systemic and CL local pathophysiology.
Protection against CL andVL due to anti-saliva cellular immu-
nity has been well established in rodents (Belkaid et al., 2000;
Kamhawi et al., 2000; Morris et al., 2001; Valenzuela et al., 2001;
Gomes et al., 2008; Oliveira et al., 2008; Ben Hadj Ahmed et al.,
2011; Rohousova et al., 2011; Xu et al., 2011). Table 1 summarizes
the outcomes of disease from the sand ﬂy and parasite combi-
nations used to test the anti-sand ﬂy saliva protective potential.
The use of Leishmania-infected sand ﬂy vector challenge, the most
accepted way to mimic Leishmania transmission in nature, has
been scarce in the literature. The use of needle inoculation of
salivary gland homogenate (SGH) plus Leishmania parasites has
been the most used surrogate. Protection has been reliably accom-
plished when animals immunized with SGH or exposed to bites
are challenged by the SGH of the same vector species plus para-
sites (Table 1). However, recently it has been shown that hamsters
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Table 1 | Protective potential of sand fly saliva against leishmaniasis.
Sand fly Treatment Animal model Challenged with Protection Reference
P. papatasi SGH BALB/C, C57BL/6 L. major +P. papatasi SGH Yes Belkaid et al. (1998), Oliveira et al. (2008),
Ahmed et al. (2010), Ben Hadj Ahmed et al.
(2010), Ben Hadj Ahmed et al. (2011)
P. papatasi Bites BALB/C, C57BL/6 L. major + infected P. papatasi Yes Kamhawi et al. (2000)
P. duboscqi Bites BALB/C L. major +P. duboscqi SGH Yes Rohousova et al. (2011)
L. longipalpis SGH Hamster L. infantum+ L. longipalpis SGH No Gomes et al. (2008)
L. longipalpis SGH C57BL/6 L. major + L. longipalpis SGH Yes Xu et al. (2011)
L. longipalpis SGH BALB/C L. amazonensis + L. longipalpis SGH Yes Thiakaki et al. (2005)
L. longipalpis SGH BALB/C L. amazonensis +P. sergenti SGH No Thiakaki et al. (2005)
L. longipalpis SGH BALB/C L. amazonensis +P. papatasi SGH No Thiakaki et al. (2005)
L. intermedia SGH BALB/C L. braziliensis + L. intermedia SGH No de Moura et al. (2007)
L. longipalpis SGH Hamster L. braziliensis + L. intermedia SGH Yes Tavares et al. (2011)
L. longipalpis SGH Hamster L. braziliensis + L. longipalpis SGH Yes Tavares et al. (2011)
immunizedwithL. longipalpis SGHareprotected against challenge
with L. braziliensis plus SGH from L. intermedia or L. longipalpis
(Tavares et al., 2011). This data may indicate that these two New
World sand ﬂies have salivary proteins that are more conserved
and hints to some level of antigenic cross-reactivity between the
salivary proteins from these two species.
Despite its conspicuous presence, the literature indicates that
anti-sand ﬂy saliva antibodies are not required for protection in
rodents (Valenzuela et al., 2001). Protective anti-saliva immunity
has been correlated with a delayed-type hypersensitivity (DTH)
reaction characterized by cellular recruitment of lymphocytes and
macrophages to the site of bite. The environment at the bite site
in immunized animals becomes rapidly inhospitable to Leishma-
nia parasites with messenger RNA of Th1 cytokines (IFN-γ and
IL-12) detected as early as 2 h after bites (Oliveira et al., 2008)
and an increased frequency of cells producing IFN-γ and IL-12
detected 6 h post-bite (Kamhawi et al., 2000). We hypothesize
that the fast cellular recruitment and Th1 polarization of the
bite site environment will result in a less successful Leishmania
establishment in the host and lead to an earlier priming of the
immune system toward an anti-Leishmania immunity (Figure 1).
The key point in the anti-saliva mediated protection is the close
proximity between the salivary proteins and the Leishmania par-
asites in the moments after the infected sand ﬂy bite, where the
anti-saliva DTH response will interfere with the initial establish-
ment of Leishmania in the host’s skin. The Leishmania parasites
establishment is disturbed as collateral damage from the anti-
saliva immunity. The microenvironment in the host skin will
change considerably from a silent infection in naïve skin to a
site highly Th1-polarized with the presence of an active cellular
inﬁltrate.
The data regarding the human cellular response to bites of sand
ﬂies is sparse. DTH has been shown at the bite site of naïve indi-
viduals sensitized to sand ﬂy bites of P. papatasi (Belkaid et al.,
2000) and L. longipalpis (Vinhas et al., 2007). Multiple exposures
to L. longipalpis induced an anti-saliva cellular immunity mea-
sured by an increased frequency of activated (CD25+) peripheral
lymphocytes and in vitro production of IFN-γ upon stimulation
with salivary glands.More recently,Abdeladhimet al. (2011) tested
individuals from an endemic area of L. major where P. papatasi
is prevalent. Peripheral blood cells were stimulated with salivary
glands from P. papatasi resulting in proliferation and IL-10 pro-
duction by CD8+ lymphocytes. When IL-10 was blocked and
CD8+cells depleted, CD4+ T cells produced IFN-γ after stimula-
tion with P. papatasi glands. Interestingly, the saliva of P. papatasi
contains adenosine, a well-characterized inducer of IL-10 and sup-
pressor of Th1 cytokines such as IL-12 and TNF-α (Hasko et al.,
2000). The direct effect of the adenosine from the saliva on in vitro
stimulation may overwhelm the acquired immune response to
sand ﬂy salivary proteins. Adenosine has been shown to be present
in large quantities in P. papatasi and P. argentipes saliva (Ribeiro
et al., 1999), but absent from L. longipalpis and P. duboscqi (Kato
et al., 2007). This fact may explain the discrepancy between the
results of stimulation with L. longipalpis and P. papatasi sali-
vary glands in humans. Follow-up studies correlating the immune
response to sand ﬂy salivary proteins over time to the outcome
of leishmaniasis will help to establish the role of the immunity to
sand ﬂy salivary proteins in protection, susceptibility, and severity
of leishmaniasis.
IMMUNE RESPONSE TO SINGLE SAND FLY SALIVARY
PROTEINS
The natural step after the consistent protection observed against
leishmaniasis after exposure to uninfected P. papatasi bites
(Kamhawi et al., 2000) or immunization with the SGH (Belkaid
et al., 1998) was the identiﬁcation of which salivary proteins were
accountable for this immunity. The low complexity of sand ﬂy
saliva (around thirty salivary proteins) made it feasible to screen
for salivary proteins that induced a DTH-Th1 response to SGH,
the hallmark of anti-saliva immunity, from several sand ﬂy species.
Identiﬁcation of the protective proteins was ﬁrst accomplished in
the P. papatasi sand ﬂy. A salivary gland protein from P. papatasi
called PpSP15was injected inmice and provided protective immu-
nity against L. major when the parasite was co-inoculated with P.
papatasi SGH (Valenzuela et al., 2001). After DNA immunization
with PpSP15, mice developed a strong DTH in response to P. pap-
atasi bites, comparable with that previously described using sand
ﬂy bites to sensitize animals (Kamhawi et al., 2000). Interestingly,
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FIGURE 1 | Hypothetical model of the protective mechanism induced by
sand fly saliva against Leishmania infection. Sensitization by uninfected
sand ﬂy bites (1) or immunization by injecting a single sand ﬂy salivary
molecule (2) leads to uptake of salivary protein(s) by antigen presenting cells
(APCs) that trafﬁc to the lymph nodes where they prime naïve CD4+ T cells
(3). When an immune host is challenged by a Leishmania-infected sand ﬂy
bite (4) it triggers a rapid recruitment of anti-saliva memory T cells, mostly
CD4+ producing IFN-γ, from the draining lymph nodes (dashed arrows) to the
site of the sand ﬂy bite. Cellular recruitment generally peaks at 48 h after
challenge by bite characterized as a delayed-type hypersensitivity reaction
(DTH) (5). CD4+T cells producing IFN-γ will activate macrophages (Mφ)
promoting Leishmania killing (Th1 response) (6).
another plasmid coding for a differentDTH-inducing salivary pro-
tein from P. papatasi, PpSP44, resulted in disease enhancement
after L. major infection, suggesting that distinct molecules from
the same vector can generate different immune responses leading
to opposite outcomes of parasite infection (Oliveira et al., 2008).
Although PpSP44 was able to induce a cellular recruitment after
recall by parasite plus saliva or by sand ﬂy bites, the cells did not
produce IFN-γ, but did produce IL-4. This result suggests that an
immune response speciﬁc to a salivary antigen that induces a cel-
lular immune response (DTH) and IFN-γ production is able to
confer protection against L. major infection. This hypothesis has
been validated in another model with a salivary protein from L.
longipalpis, LJM19, tested in a hamster model of VL (Gomes et al.,
2008). Hamsters immunized with LJM19 and challenged with L.
infantum plus L. longipalpis SGH,were able to maintain a low par-
asite load in the spleen and liver 5months after infection, with an
overall high IFN-γ/TGF-β ratio and inducible NOS expression in
both organs. LJM19-immunized hamsters induced a strong DTH
with IFN-γproduction 48 h after exposure to uninfected sand ﬂy
bites, a consistent predictor of protection. The expression of IFN-
γ at the site of bite can partly explain the reduced number of L.
infantum in the spleen and liver of LJM19-immunized hamsters.
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The early immune response generated by LJM19 could promote a
direct parasite killing and/or priming of anti-Leishmania immu-
nity. In the same study, another salivary protein of L. longipalpis,
LJM11, protected hamsters against VL up to 2months post-
infection with L. infantum (Gomes et al., 2008). The protection
was partial and associated with a DTH response composed mainly
of macrophages and lymphocytes. More recently, when tested in
a model of CL, LJM11 conferred protective immunity against L.
major infection (Xu et al., 2011). The protection was correlated
with a strong DTH induced in C57BL/6 strain mouse following
exposure to L. longipalpis SGH. Additionally, splenocytes of mice
exposed to uninfected sand ﬂy bites produced IFN-γ upon stimu-
lation with recombinant LJM11 protein, suggesting the induction
of a systemic Th1 immunity by this molecule. Using the hamster
model ofVL,da Silva et al. (2011) combined LJM19withKMP11, a
DNA plasmid coding Leishmania antigen, and showed a protective
effect in hamsters after challenge with L. infantum plus L. longi-
palpis SGH. The combined plasmids induced IFN-γ production in
the draining lymphnodes at 7,14, and 21 days post-immunization.
Increased IFN-γ/IL-10 and IFN-γ/TGF-β ratios were observed in
the spleen 2 and 5months after challengewith a subsequent reduc-
tion in parasite load in the spleen and liver. Like LJM11,LJM19 also
showed the capacity for inducing a protective immune response
against different species of Leishmania transmitted by different
species of sand ﬂy. Hamsters immunized with LJM19 controlled
the infection against L. braziliensis plus SGH of L. intermedia, its
natural vector (Tavares et al., 2011). Table 2 summarizes the role of
sand ﬂy salivary proteins in protection against Leishmania infec-
tion. The ability of these salivary proteins to induce Th1 cytokines
is remarkable, considering the absence of adjuvants. It remains
unknown how these sand ﬂy salivary proteins efﬁciently stimu-
late the immune system triggering a Th1 response. We believe
that these protective salivary proteins may be interacting with the
innate immune system, working in a self-adjuvant manner. Taken
together, an early anti-saliva cellular immunity (DTH) and the
presence of a Th1 immune response mainly characterized by the
presence of IFN-γ against the salivary proteins inoculated during
challenge, alter the outcomeof Leishmania infection and correlates
with protection. It reinforces the concept of using components of
arthropod saliva as a novel strategy against vector-borne diseases.
CHALLENGES FOR VACCINE DEVELOPMENT
The immune response to sandﬂy salivary proteins has been consis-
tently shown to protect rodents against leishmaniasis in laboratory
settings. From identiﬁcation in rodents to translation into mar-
ketable vaccine candidates, protective sand ﬂy salivary proteins
have to overcome several hurdles including intrinsic genetic vari-
ation among sand ﬂy populations, variations between ﬁeld and
colonized sand ﬂies, and the possibility of causing allergies or
desensitization.
Recently, researchers working with P. papatasi in Tunisia
(Ahmed et al., 2010; Ben Hadj Ahmed et al., 2010, 2011) showed
that colonization of sand ﬂies favors protection against Leishma-
nia. Protection accomplished using long-term colonized sand ﬂies
(F29) could not be reproduced with ﬁrst generation P. papatasi.
Surprisingly, colonization for ﬁve generations led to the acquisi-
tion of the protective qualities against Leishmaniasis of sand ﬂy
saliva. The nature of the changes remains unknown. One pos-
sible explanation for these ﬁndings may be related to amount
of salivary protein present in the colonized vs. wild caught ﬂies
rather than a change or a rapid loss of genetic variability. It is
very difﬁcult to estimate the amount of salivary proteins in wild
caught ﬂies compared to colonized ﬂies in which the maximum
amount will normally peak after day 4 and will decrease after day
12. Therefore, these experiments may need to be repeated normal-
izing the amount of salivary proteinswhenusing colonized vs. wild
caught ﬂies. In fact, Laurenti et al. (2009a,b) showed that salivary
proteins from ﬁeld-captured L. longipalpis impacted the immune
system differently from laboratory-reared sand ﬂies. Nevertheless,
this work clearly indicates (by SDS-PAGE analysis) that one sali-
vary gland pair from wild caught sand ﬂies had fewer amounts
of proteins when compared to a salivary gland pair from colo-
nized ﬂies. This supports the likelihood that amount and not the
type of saliva is responsible for these effects. Currently, most of
the published work on sand ﬂy saliva immunity relies on long-
term colonized sand ﬂies. We have compared by transcriptomic
Table 2 | Sand fly salivary proteins tested in animal model of leishmaniasis.
Salivary protein candidate (sand fly) Challenged with Immune response Protection Reference
Maxadilan1 (L. longipalpis)4 L. major + L. longipalpis SGH Cellular and humoral Yes Morris et al. (2001)
PpSP152 (P. papatasi )4 L. major +P. papatasi SGH Cellular and humoral Yes Valenzuela et al. (2001)
PpSP442 (P. papatasi )4 L. major +P. papatasi SGH Cellular and humoral No Oliveira et al. (2008)
LJM192 (L. longipalpis)3 L. infantum+ L. longipalpis SGH Cellular Yes Gomes et al. (2008)
LJM192 (L. longipalpis)3 L. infantum+ L. longipalpis SGH Cellular Yes da Silva et al. (2011)
LJM192 (L. longipalpis)4 L. braziliensis + L. intermedia SGH Cellular Yes Tavares et al. (2011)
LJM192 (L. longipalpis)4 L. braziliensis + L. longipalpis SGH Cellular Yes Tavares et al. (2011)
LJM172 (L. longipalpis)3 L. infantum+ L. longipalpis SGH Cellular and humoral No Gomes et al. (2008)
LJL112 (L. longipalpis)3 L. infantum+ L. longipalpis SGH Humoral No Gomes et al. (2008)
LJM112 (L. longipalpis)3 L. infantum+ L. longipalpis SGH Cellular and humoral Partial Gomes et al. (2008)
LJM112 (L. longipalpis)4 L. major + L. longipalpis SGH Cellular and humoral Yes Xu et al. (2011)
LJL1432 (L. longipalpis)4 L. major + L. longipalpis SGH Cellular No Xu et al. (2011)
1Peptide immunization; 2DNA immunization; 3VL model; 4CL model.
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analysis colonized vs. wild caught ﬂies even from different geo-
graphical areas and to our surprise the level of identity between
the different salivary transcripts was very high (Kato et al., 2006).
However, it will be important, to perform an in depth proteomics
or deep sequencing analysis to determine if there is a speciﬁc dif-
ference between the salivary proteins of colonized and wild caught
sand ﬂies.
Individuals from endemic areas are likely bitten by sand ﬂies
everyday and possibly many times a day. The effect of multiple
exposures has been investigated in BALB/c mice that were exposed
to bites of thirty P. duboscqi females every week for 15weeks
(Rohousova et al., 2011). After multiple exposures the mice lost
the ability to mount a protective anti-saliva immune response.
This raised concerns that humans living in endemic areas may
be desensitized over time. This hypothesis needs to be tested in
humans from areas where sand ﬂies are prevalent.
Another possible obstacle that needs to be addressed is the
genetic variation among populations of sand ﬂies. It has been
reported that some salivary proteins, i.e., maxadilan from L.
longipalpis, are highly polymorphic depending on geographi-
cal location (Lanzaro et al., 1999). Conversely, PpSP15 from
P. papatasi has been shown to have little diversifying selection
being mostly conserved at the amino acid level from different
populations in Sudan, Egypt, Jordan, Israel, and Saudi Arabia
(Elnaiem et al., 2005). These data indicate that a vaccine candi-
date from sand ﬂy salivary proteins that is conserved and would
potentially work across different geographical locations can be
identiﬁed.
We also advocate that vaccine candidates to leishmaniasis need
to be tested against a Leishmania-infected sand ﬂy-challenge.
Peters et al. (2009) have demonstrated that a challenge with
infected sand ﬂies is more virulent, overcoming the protection
otherwise conferred by a Leishmania vaccine to the challenge
with parasites by needle inoculation. The infected challenge incor-
porates several unique features: 1-sand ﬂy saliva; 2-promatigote
secretory gel (Rogers et al., 2004, 2009); 3-infective metacyclic
Leishmania parasites; 4-Sand ﬂy probing; and damage of the host’s
skin during the transmission. This is of great signiﬁcance and com-
plexity and will be difﬁcult to mimic. Therefore, vector challenge
should be used in order to advance vaccine development toward
an effective Leishmania vaccine for humans.
CONCLUSION
Immunity against sand ﬂy salivary proteins and their potential
as components of a Leishmania vaccine continues to be over-
looked. While signiﬁcant progress has been made to understand
the immune response to sand ﬂy saliva in humans and rodents, a
deeper understanding of the contributions of the innate and adap-
tive immune system is needed. Studies in rodents where sand ﬂy
salivary proteins are tested in conjunction with parasite candidates
are desirable. Moreover, more studies in humans and canids from
endemic areas correlating anti-saliva cellular immune response
and leishmaniasis outcome are essential for the advancement of
the vector-Leishmania ﬁeld. The experimental studies reviewed
here highlight that immunity to salivary proteins are a promising
supplement to conventional anti-Leishmania vaccine approaches.
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